메인비쥬얼

Humedix Gallery Humedix grows into a global health care company

컨텐츠

Title Humedix signed a joint development and licensing agreement with G2GBIO and KOREA PHARMA for a long-acting dementia treatment
Author Master Date 2022-10-05
Attached file

Humedix signed a contract for joint development and licensing of donepezil injection for Alzheimer`s dementia treatment with G2GBio and Korea Pharma

at the headquarters of G2G Bio in Osong, Chungcheongbuk-do on October 04, 2022.

 

KakaoTalk_20221004_131914656_05.jpg

 

 

 

단체사진 1.jpg

Total 77, 1/8 Page
No Title Author Date Hits
77 Humedix and GCS sign an exclusive domestic sales contract for ‘.. Master 2024-03-04 149
76 Humedix, Ensolbiosciences sign an exclusive contract in Korea for.. Master 2023-07-27 353
75 Humedix, Ensolbioscience and Investment Agreement Ceremony Master 2023-02-21 325
-74- Humedix signed a joint development and licensing agreement with G.. Master 2022-10-05 456
73 Humedix and Wonbiogen signed an exclusive domestic sales contract.. Master 2022-09-19 511
72 Humedix, Epibiotech and `hair loss treatment joint development` b.. Master 2022-09-07 366
71 Humedix, MyOne pharm and Derma Ellavie Cosmetics Supply Contract Master 2022-07-21 468
70 Huons Group Delivers Support for Jecheon International Music and .. Master 2022-07-19 471
69 Humedix and Exostemtech signed an MOU for joint development of ex.. Master 2022-04-05 534
68 Humedix, Ministry of Food and Drug Safety Visits Jecheon Factory Master 2022-02-22 462